Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
View Patent ↗The present invention relates to a treatment of an autoimmune demyelinating disease/disorder. Also included in the present invention is the use of bone marrow stromal cells for the treatment of multiple sclerosis (MS).
1. A method of treating a mammal having an autoimmune demyelinating disease/disorder multiple sclerosis (MS), the method comprising isolating a stromal cell from a bone marrow sample, and administering said stromal cell to said mammal, wherein the presence of said stromal cell in the CNS of the mammal effects treatment of MS, and wherein said stromal cell is administered to said mammal by a route selected from the group consisting of: transplantation, intravascular, intracerebral, intravenous, epidural, intraspinal, intrasternal, intra-articular, intra-synovial, and intra-arterial.
2. The method of claim 1 , wherein said stromal cell is selected from the group consisting of an autologous stromal cell, an allogeneic stromal cell, a syngeneic stromal cell, and a xenogeneic stromal cell, with respect to said mammal.
3. The method of claim 1 , wherein said mammal is a human.
4. The method of claim 1 , wherein said stromal cell is derived from a human donor.
5. The method of claim 1 , wherein prior to administering said stromal cell to said mammal, said cell is cultured in vitro.
6. The method of claim 1 , wherein said stromal cell is administered to said mammal by transplantation.
7. The method of claim 1 , wherein said stromal cell is administered to said mammal by intravenous route.
8. The method of claim 1 , wherein said stomal cells are administered in an amount effective to reduce axonal fiber loss in the cells of the mammal.
9. The method of claim 1 , wherein said stromal cells are administered in an amount effective to reduce demyelination in the cells of the mammal.